Study: BAL samples that reveal high fungal and bacterial loads in COVID patients with ARDS are indicators of poor outcomes.

Patient Safety

BAL Findings Can Help Predict Outcomes In COVID Patients With ARDS

“Disentangling this web of microbial, pathogen and host dynamics is the only way we will be able to risk-stratify patients and identify treatable traits."

High bacterial and fungal burden detected in bronchoalveolar lavage (BAL) samples of COVID-19 patients with acute respiratory distress (ARDS) has been linked to higher deaths.

The study, out of Amsterdam, was designed to assess the relationship between lung microbiota and clinical outcomes of COVID-19-related ARDS.

Published in the American Journal of Respiratory and Critical Care Medicine, the study included 114 mechanically ventilated patients with COVID-19 and ARDS who underwent bronchoscopy with BAL.

Researchers found that those patients with the highest bacterial and fungal burdens were less likely to be extubated and to survive than those with lower levels. More than half of the patients in the study died.

“Our findings confirm the importance of the lung microbiome in ARDS and COVID-19 and highlight the significance of the — often overlooked — pulmonary fungal burden in critically ill patients,” Dr. Robert F.J. Kullberg and others wrote.

The study’s endpoint was defined as successful extubation within 60 days after intubation.

The authors say this study validates earlier research which showed increased bacterial burden to be associated with higher mortality but is the first to link a higher fungal burden with high fatality in COVID patients with ARDS.

“In the context of other investigations on lower airway samples from critically ill patients with COVID-19, these results solidify the notion that it is not just uncontrollable SARS-CoV-2 infection that kills patients with COVID-19, though that’s likely one big part of it,” wrote authors of a related editorial.

More research is needed, they added.

“Disentangling this web of microbial, pathogen and host dynamics is the only way we will be able to risk-stratify patients and identify treatable traits,” the authors of the editorial wrote.

More Pulmonology Articles
Q&A: Exploring Single-Use Efficiency in the ICU
Performing Procedures
Dr. James M. Horowitz explains why single-use bronchoscopes will remain the primary visualization tool in one New York City hospital’s ICU post-pandemic.
Here’s What High Readmissions Costs Hospitals
Analyzing Value
After 10 years of monitoring, nearly half of the nation’s hospitals have readmission rates high enough to prompt reduced Medicare payments.
More From Single-Use Endoscopy
Free Resources to Celebrate the 10th Anniversary of GI Nurses and Associates Week

Gastrointestinal Endoscopy Applications

The society provides you with a list of ideas to recognize the GI nurses in your department.

Patient Safety Awareness Week is a good opportunity to rethink infection prevention practices.

Patient Safety Awareness Week

Errors or instances of preventable harm in healthcare can have a wide range of physical, emotional, and financial effects on patients, according to the IHI, which is why the organization recognizes Patient Safety Awareness Week annually.

Patient success stories may help healthcare workers overcome burnout.

Critical Care

Post- ICU clinics designed to help patients recover from critical illness may serve the dual purpose of helping their caregivers overcome burnout, according to a new study.